Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple Myeloma
Clinical trial NCT02874742 · COMPLETED
Trial details
- NCT number
- NCT02874742
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-29
- Primary completion
- 2019-01-25
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.